Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4559792
Max Phase: Preclinical
Molecular Formula: C20H18N2O3S
Molecular Weight: 366.44
Molecule Type: Unknown
Associated Items:
ID: ALA4559792
Max Phase: Preclinical
Molecular Formula: C20H18N2O3S
Molecular Weight: 366.44
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1ccc(S(=O)(=O)NN=C(c2ccccc2)c2ccccc2)cc1
Standard InChI: InChI=1S/C20H18N2O3S/c1-25-18-12-14-19(15-13-18)26(23,24)22-21-20(16-8-4-2-5-9-16)17-10-6-3-7-11-17/h2-15,22H,1H3
Standard InChI Key: ILOQXYKFSMNFRX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 366.44 | Molecular Weight (Monoisotopic): 366.1038 | AlogP: 3.43 | #Rotatable Bonds: 6 |
Polar Surface Area: 67.76 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.86 | CX Basic pKa: 0.23 | CX LogP: 4.31 | CX LogD: 4.31 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.54 | Np Likeness Score: -0.86 |
1. Arshia, Begum F, Almandil NB, Lodhi MA, Khan KM, Hameed A, Perveen S.. (2019) Synthesis and urease inhibitory potential of benzophenone sulfonamide hybrid in vitro and in silico., 27 (6): [PMID:30738655] [10.1016/j.bmc.2019.01.043] |
Source(1):